4D bioprinting shape-morphing tissues using phototunable supramolecular hydrogels

morphoPRINT aims to develop a dynamic hydrogel platform for bioprinted tissues that enables programmable shape-morphing, facilitating the creation of functional organs through controlled volumetric growth.

Subsidie
€ 1.499.906
2023

Projectdetails

Introduction

During embryonic development, organs emerge through highly dynamic processes driven by complex shape-transformations that sculpt their final shape, composition, and function. Despite this, existing approaches to organ bioprinting employ static hydrogels that are not capable of supporting morphogenetic shape changes.

Challenges in Current Approaches

Further, we lack an understanding of how key morphogenetic forces such as volumetric tissue growth can be leveraged to re-engineer fundamental tissue shape-morphing behaviours such as:

  1. Bending
  2. Buckling
  3. Bulging
  4. Twisting

These are major barriers preventing the design of bioprinted tissues that undergo shape-transformations essential for their evolution into a functional final form.

Project Goals

Recognising this, the goal of morphoPRINT is to develop a dynamic hydrogel platform that can spatially turn “on” or “off” volumetric growth in bioprinted tissues to direct 4D shape-morphing. Additionally, we aim to use this platform to re-engineer morphogenetic shape changes that sculpt the tissue into a more mature form.

Technological Advances

To realise this goal, we propose ground-breaking technological advances to create hydrogels with independent networks of:

  1. Supramolecular crosslinks that support volumetric growth
  2. Photoresponsive covalent crosslinks that can be spatially activated to resist volumetric growth

Research Exploration

We will use this platform to explore how spatial patterns of volumetric growth can drive tissue bending, buckling, and bulging. This exploration will lead to a new conceptual understanding of the physical principles that drive tissue shape-morphing.

Application of Principles

We will then apply these principles towards the design of bioprinted heart tubes that undergo embryonic-like looping into an early 4-chamber structure.

Conclusion

MorphoPRINT will enable, for the first time, bioprinted organs that undergo programmable shape-morphing. This will set the stage for a new horizon in organ-engineering research focused on recapitulating physical aspects of morphogenesis rather than just the end-stage geometrical structure of the organ.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.499.906
Totale projectbegroting€ 1.499.906

Tijdlijn

Startdatum1-5-2023
Einddatum30-4-2028
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • UNIVERSITY OF GALWAYpenvoerder

Land(en)

Ireland

Vergelijkbare projecten binnen European Research Council

ERC Proof of...

A novel support material for 3D bioprinting and post-printing tissue growth: Print and Grow

The "Print and Grow" project aims to enhance 3D bioprinting stability and viability of tissue constructs through a novel microgel support, optimizing for diverse tissue types and in vivo applications.

€ 150.000
ERC Starting...

Engineering the Origin of Human Shape: Defining Patterns and Axes in the Early Stage of 3D Pluripotency

OriSha aims to revolutionize in vitro human embryonic development modeling by using a hydrogel-microfluidic system to control biochemical signals for studying neural tube morphogenesis.

€ 1.499.633
ERC Consolid...

Holographic Optical Tweezing Bioprinting (HOTB): Towards precise manipulation of cells for artificial multi-scaled vascularized tissues/organ printing.

The HOT-BIOPRINTING project aims to revolutionize tissue engineering by developing a holographic optical tweezing bioprinter for high-resolution, automated 3D bioprinting of complex, vascularized tissues.

€ 1.965.525
ERC Starting...

Jam with the flow: Microgel-based (bio)inks that assemble during printing

Developing microgel-based materials for extrusion-based 3D printing to create stable, heterogeneous scaffolds with precise control over local properties for biomedical applications.

€ 2.075.000
ERC Consolid...

3D-assembly of interactive microgels to grow in vitro vascularized, structured, and beating human cardiac tissues in high-throughput

HEARTBEAT aims to create personalized, vascularized millimeter-scale heart tissues using innovative microgel assemblies to enhance stem cell interactions and mimic native environments.

€ 2.969.219

Vergelijkbare projecten uit andere regelingen

EIC Pathfinder

Smart 4D biodegradable metallic shape-shifting implants for dynamic tissue restoration

BIOMET4D aims to revolutionize reconstructive surgery with shape-morphing implants for dynamic tissue restoration, enhancing regeneration while reducing costs and invasiveness.

€ 4.039.541
EIC Pathfinder

High-throughput ultrasound-based volumetric 3D printing for tissue engineering

SONOCRAFT aims to revolutionize myocardial cell construct bioprinting by combining rapid volumetric printing with ultrasonic manipulation to create functional cardiac models for drug testing and disease research.

€ 2.999.625
EIC Pathfinder

Next Generation 3D Tissue Models: Bio-Hybrid Hierarchical Organoid-Synthetic Tissues (Bio-HhOST) Comprised of Live and Artificial Cells.

Bio-HhOST aims to create bio-hybrid materials with living and artificial cells for dynamic communication, enhancing tissue modeling and reducing animal use in drug research.

€ 1.225.468
EIC Pathfinder

PRInted Symbiotic Materials as a dynamic platform for Living Tissues production

PRISM-LT aims to develop a flexible bioprinting platform using hybrid living materials to enhance stem cell differentiation with engineered helper cells for biomedical and food applications.

€ 2.805.403
EIC Transition

Better Bioprinting by Light-sheet Lithography

B-BRIGHTER aims to develop a novel high-speed bioprinting technology for creating complex engineered tissues, enhancing drug testing and therapeutic applications while fostering healthcare innovation.

€ 2.093.331